Cargando…

Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization

INTRODUCTION: Strong correlation has been demonstrated between tumor dose and response and between healthy liver dose and side effects. Individualized dosimetry is increasingly recommended in the current clinical routine. However, hepatic and tumor segmentations could be complex in some cases. The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyers, Nicolas, Jadoul, Alexandre, Bernard, Claire, Delwaide, Jean, Lamproye, Anne, Detry, Olivier, Honoré, Pierre, Gerard, Laurent, Hustinx, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218042/
https://www.ncbi.nlm.nih.gov/pubmed/32399636
http://dx.doi.org/10.1186/s40658-020-00302-1
_version_ 1783532713555263488
author Meyers, Nicolas
Jadoul, Alexandre
Bernard, Claire
Delwaide, Jean
Lamproye, Anne
Detry, Olivier
Honoré, Pierre
Gerard, Laurent
Hustinx, Roland
author_facet Meyers, Nicolas
Jadoul, Alexandre
Bernard, Claire
Delwaide, Jean
Lamproye, Anne
Detry, Olivier
Honoré, Pierre
Gerard, Laurent
Hustinx, Roland
author_sort Meyers, Nicolas
collection PubMed
description INTRODUCTION: Strong correlation has been demonstrated between tumor dose and response and between healthy liver dose and side effects. Individualized dosimetry is increasingly recommended in the current clinical routine. However, hepatic and tumor segmentations could be complex in some cases. The aim of this study is to assess the reproducibility of the tumoral and non-tumoral liver dosimetry in selective internal radiation therapy (SIRT). MATERIAL AND METHODS: Twenty-three patients with hepatocellular carcinoma (HCC) who underwent SIRT with glass microspheres were retrospectively included in the study. Tumor (TV) and total liver volumes (TLV), and mean absorbed doses in tumoral liver (TD) and non-tumoral liver (THLD) were determined on the (90)Y PET/CT studies using Simplicit90YTM software, by three independent observers. Dosimetry datasets were obtained by a medical physicist helped by a nuclear medicine (NM) physician with 10 years of experience (A), by a NM physician with 4-year experience (B), and by a resident who first performed 10 dosimetry assessments as a training (C). Inter-observer agreement was evaluated using intra-class correlation coefficients (ICC), coefficients of variation (CV), Bland-Altman plots, and reproducibility coefficient (RDC). RESULTS: A strong agreement was observed between all three readers for estimating TLV (ICC 0.98) and THLD (ICC 0.97). Agreement was lower for TV delineation (ICC 0.94) and particularly for TD (ICC 0.73), especially for the highest values. Regarding TD, the CV (%) was 26.5, 26.9, and 20.2 between observers A and B, A and C, and B and C, respectively, and the RDC was 1.5. Regarding THLD, it was 8.5, 12.7, and 9.4, and the RDC was 1.3. CONCLUSION: Using a standardized methodology, and regardless of the different experiences of the observers, the estimation of THLD is highly reproducible. Although the reproducibility of the assessment of tumor irradiation is overall quite high, large variations may be observed in a limited number of patients.
format Online
Article
Text
id pubmed-7218042
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-72180422020-05-15 Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization Meyers, Nicolas Jadoul, Alexandre Bernard, Claire Delwaide, Jean Lamproye, Anne Detry, Olivier Honoré, Pierre Gerard, Laurent Hustinx, Roland EJNMMI Phys Original Research INTRODUCTION: Strong correlation has been demonstrated between tumor dose and response and between healthy liver dose and side effects. Individualized dosimetry is increasingly recommended in the current clinical routine. However, hepatic and tumor segmentations could be complex in some cases. The aim of this study is to assess the reproducibility of the tumoral and non-tumoral liver dosimetry in selective internal radiation therapy (SIRT). MATERIAL AND METHODS: Twenty-three patients with hepatocellular carcinoma (HCC) who underwent SIRT with glass microspheres were retrospectively included in the study. Tumor (TV) and total liver volumes (TLV), and mean absorbed doses in tumoral liver (TD) and non-tumoral liver (THLD) were determined on the (90)Y PET/CT studies using Simplicit90YTM software, by three independent observers. Dosimetry datasets were obtained by a medical physicist helped by a nuclear medicine (NM) physician with 10 years of experience (A), by a NM physician with 4-year experience (B), and by a resident who first performed 10 dosimetry assessments as a training (C). Inter-observer agreement was evaluated using intra-class correlation coefficients (ICC), coefficients of variation (CV), Bland-Altman plots, and reproducibility coefficient (RDC). RESULTS: A strong agreement was observed between all three readers for estimating TLV (ICC 0.98) and THLD (ICC 0.97). Agreement was lower for TV delineation (ICC 0.94) and particularly for TD (ICC 0.73), especially for the highest values. Regarding TD, the CV (%) was 26.5, 26.9, and 20.2 between observers A and B, A and C, and B and C, respectively, and the RDC was 1.5. Regarding THLD, it was 8.5, 12.7, and 9.4, and the RDC was 1.3. CONCLUSION: Using a standardized methodology, and regardless of the different experiences of the observers, the estimation of THLD is highly reproducible. Although the reproducibility of the assessment of tumor irradiation is overall quite high, large variations may be observed in a limited number of patients. Springer International Publishing 2020-05-12 /pmc/articles/PMC7218042/ /pubmed/32399636 http://dx.doi.org/10.1186/s40658-020-00302-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Meyers, Nicolas
Jadoul, Alexandre
Bernard, Claire
Delwaide, Jean
Lamproye, Anne
Detry, Olivier
Honoré, Pierre
Gerard, Laurent
Hustinx, Roland
Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
title Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
title_full Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
title_fullStr Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
title_full_unstemmed Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
title_short Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
title_sort inter-observer variability of (90)y pet/ct dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218042/
https://www.ncbi.nlm.nih.gov/pubmed/32399636
http://dx.doi.org/10.1186/s40658-020-00302-1
work_keys_str_mv AT meyersnicolas interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization
AT jadoulalexandre interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization
AT bernardclaire interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization
AT delwaidejean interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization
AT lamproyeanne interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization
AT detryolivier interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization
AT honorepierre interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization
AT gerardlaurent interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization
AT hustinxroland interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization